2022
DOI: 10.1053/j.gastro.2022.01.058
|View full text |Cite
|
Sign up to set email alerts
|

Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
49
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(49 citation statements)
references
References 185 publications
0
49
0
Order By: Relevance
“…In addition, prenatal fatty liver must provoke severe insulin resistance in the offspring of HFD-fed dams beginning early in life, accompanying the inhibition of insulin-stimulated glucose uptake. CD-feeding with insulin resistance after birth might lead to malnutrition, such as kwashiorkor and marasmus 51 , and exacerbate steatohepatitis.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, prenatal fatty liver must provoke severe insulin resistance in the offspring of HFD-fed dams beginning early in life, accompanying the inhibition of insulin-stimulated glucose uptake. CD-feeding with insulin resistance after birth might lead to malnutrition, such as kwashiorkor and marasmus 51 , and exacerbate steatohepatitis.…”
Section: Discussionmentioning
confidence: 99%
“…NAFLD is closely raleted to metabolic syndrome and the pathogenesis of which is studied mainly based on metabonomics ( 11 , 12 ). In recent years, there is increasing evidence showing that the NAFLD related to the imbalance in intestinal flora ( 13 ). The latest study, recently published in science translational medicine, provides predictions of long-term NAFLD development based on clinical indicators of NAFLD patients, intestinal flora macrogenomics and metabonomics data ( 14 ).…”
Section: Introductionmentioning
confidence: 99%
“…It has been shown that NAFLD is strictly associated with alterations in gut microbiota and intestinal permeability [ 9 ]. This can, in turn, affect liver inflammation via the translocation of damage- and pathogen-associated molecular patterns (DAMPs and PAMPs, respectively) and, particularly of bacterial compounds (i.e., endotoxins), to the liver through portal circulation [ 10 ]. In this light, Escherichia Coli -derived lipopolysaccharide (LPS) has been identified as a driver of liver inflammation both in experimental models and in human NAFLD [ 11 ]; its deleterious effects are largely mediated by the activation of toll-like receptor 4 (TLR4) pathways within the liver [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…This can, in turn, affect liver inflammation via the translocation of damage- and pathogen-associated molecular patterns (DAMPs and PAMPs, respectively) and, particularly of bacterial compounds (i.e., endotoxins), to the liver through portal circulation [ 10 ]. In this light, Escherichia Coli -derived lipopolysaccharide (LPS) has been identified as a driver of liver inflammation both in experimental models and in human NAFLD [ 11 ]; its deleterious effects are largely mediated by the activation of toll-like receptor 4 (TLR4) pathways within the liver [ 10 ]. Therefore, the modulation of gut physiology and microbiota composition in NAFLD patients might represent a therapeutic approach to attenuate liver inflammation and, eventually, slow disease progression towards NASH.…”
Section: Introductionmentioning
confidence: 99%